Company Seeks Additional Partnerships to Increase Revenue -- Sinovac Biotech Ltd. (AMEX:SVA), a China-based maker of vaccines, signed an Exclusive Promotion Service Agreement with the China division of GlaxoSmithKline (GSK) to promote and market Anflu. Anflu is a seasonal flu vaccine, developed and manufactured by Sinovac. As we reported earlier (see story), Anflu has not been a big seller for Sinovac in the past. More details...